<?xml version="1.0" encoding="utf-8" ?><rss version="2.0"
     xmlns:atom="http://www.w3.org/2005/Atom"
     xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
     xmlns:media="http://search.yahoo.com/mrss/">

   <channel>
       <title>SARS-CoV-2 - ÖQUASTA</title>
       <description><![CDATA[]]></description>
       <link>https://oequasta.at/de/publikationen/cov-2?format=html</link>
              <lastBuildDate>Wed, 24 Apr 2024 13:00:36 +0200</lastBuildDate>
       <atom:link href="https://oequasta.at/de/publikationen/cov-2?format=rss" rel="self" type="application/rss+xml"/>
       <language>de-DE</language>
       <sy:updatePeriod>hourly</sy:updatePeriod>
       <sy:updateFrequency>1</sy:updateFrequency>

              <item>
           <title>External quality assessments for SARS CoV 2 genome detection in Austria</title>
           <link>https://oequasta.at/de/publikationen/cov-2/572-external-quality-assessments-for-sars-cov-2-genome-detection-in-austria?format=html</link>
           <enclosure url="https://oequasta.at/de/publikationen/cov-2/572-external-quality-assessments-for-sars-cov-2-genome-detection-in-austria/file" length="735100" type="application/pdf" />
           <media:content
                url="https://oequasta.at/de/publikationen/cov-2/572-external-quality-assessments-for-sars-cov-2-genome-detection-in-austria/file"
                fileSize="735100"
                type="application/pdf"
                medium="document"
           />
           <media:title type="plain">External quality assessments for SARS CoV 2 genome detection in Austria</media:title>
           <media:description type="html"><![CDATA[<p>Christoph Buchta, Stephan W. Aberle, Irene Görzer, Andrea Griesmacher, Mathias M. Müller, Erich Neuwirth, Elisabeth Puchhammer-Stöckl, Lukas Weseslindtner, Jeremy V. Camp</p>
<p>wiener klinische Wochenschrift, Received: 13 December 2023 / Accepted: 19 March 2024<br>DOI:10.1007/s00508-024-02353-1</p>]]></media:description>
                      <guid isPermaLink="true">https://oequasta.at/de/publikationen/cov-2/572-external-quality-assessments-for-sars-cov-2-genome-detection-in-austria?format=html</guid>
           <description><![CDATA[<p>Christoph Buchta, Stephan W. Aberle, Irene Görzer, Andrea Griesmacher, Mathias M. Müller, Erich Neuwirth, Elisabeth Puchhammer-Stöckl, Lukas Weseslindtner, Jeremy V. Camp</p>
<p>wiener klinische Wochenschrift, Received: 13 December 2023 / Accepted: 19 March 2024<br>DOI:10.1007/s00508-024-02353-1</p>]]></description>
           <author>office@webkonzepte.at (Super User)</author>
           <category>SARS CoV-2</category>
           <pubDate>Wed, 24 Apr 2024 13:00:36 +0200</pubDate>
       </item>
              <item>
           <title>Performance of SARS-CoV-2 nucleic acid amplification testing in Austria as measured by external quality assessment schemes during 3 years of the COVID-19 pandemic: an observational retrospective study</title>
           <link>https://oequasta.at/de/publikationen/cov-2/570-piis2666524723002860?format=html</link>
           <enclosure url="https://oequasta.at/de/publikationen/cov-2/570-piis2666524723002860/file" length="849207" type="application/pdf" />
           <media:content
                url="https://oequasta.at/de/publikationen/cov-2/570-piis2666524723002860/file"
                fileSize="849207"
                type="application/pdf"
                medium="document"
           />
           <media:title type="plain">Performance of SARS-CoV-2 nucleic acid amplification testing in Austria as measured by external quality assessment schemes during 3 years of the COVID-19 pandemic: an observational retrospective study</media:title>
           <media:description type="html"><![CDATA[<p>Christoph Buchta, Stephan W Aberle, Franz Allerberger, Bernhard Benka, Irene Görzer, Andrea Griesmacher, Wolfgang Hübl, Wolfgang Huf, Stylianos Kapiotis, Mathias M Müller, Erich Neuwirth, Elisabeth Puchhammer-Stöckl, Lukas Weseslindtner, Jeremy V Camp</p>
<p>Lancet Microbe 2023; Published Online November 15, 2023<br />DOI: 10.1016/S2666-5247(23)00286-0</p>]]></media:description>
                      <guid isPermaLink="true">https://oequasta.at/de/publikationen/cov-2/570-piis2666524723002860?format=html</guid>
           <description><![CDATA[<p>Christoph Buchta, Stephan W Aberle, Franz Allerberger, Bernhard Benka, Irene Görzer, Andrea Griesmacher, Wolfgang Hübl, Wolfgang Huf, Stylianos Kapiotis, Mathias M Müller, Erich Neuwirth, Elisabeth Puchhammer-Stöckl, Lukas Weseslindtner, Jeremy V Camp</p>
<p>Lancet Microbe 2023; Published Online November 15, 2023<br />DOI: 10.1016/S2666-5247(23)00286-0</p>]]></description>
           <author>office@webkonzepte.at (Super User)</author>
           <category>SARS CoV-2</category>
           <pubDate>Fri, 17 Nov 2023 09:55:56 +0100</pubDate>
       </item>
              <item>
           <title>Do not blindly trust negative diagnostic test results!</title>
           <link>https://oequasta.at/de/publikationen/cov-2/569-piis2666524723003403?format=html</link>
           <enclosure url="https://oequasta.at/de/publikationen/cov-2/569-piis2666524723003403/file" length="141215" type="application/pdf" />
           <media:content
                url="https://oequasta.at/de/publikationen/cov-2/569-piis2666524723003403/file"
                fileSize="141215"
                type="application/pdf"
                medium="document"
           />
           <media:title type="plain">Do not blindly trust negative diagnostic test results!</media:title>
           <media:description type="html"><![CDATA[<p>Christoph Buchta, Heinz Zeichhardt, Andreas Osterman, Lucy A Perrone, Andrea Griesmacher</p>]]></media:description>
                      <guid isPermaLink="true">https://oequasta.at/de/publikationen/cov-2/569-piis2666524723003403?format=html</guid>
           <description><![CDATA[<p>Christoph Buchta, Heinz Zeichhardt, Andreas Osterman, Lucy A Perrone, Andrea Griesmacher</p>]]></description>
           <author>office@webkonzepte.at (Super User)</author>
           <category>SARS CoV-2</category>
           <pubDate>Fri, 17 Nov 2023 09:55:54 +0100</pubDate>
       </item>
              <item>
           <title>Ignoring testing performance</title>
           <link>https://oequasta.at/de/publikationen/cov-2/560-ignoring-testing-performance?format=html</link>
           <enclosure url="https://oequasta.at/de/publikationen/cov-2/560-ignoring-testing-performance/file" length="47100" type="application/pdf" />
           <media:content
                url="https://oequasta.at/de/publikationen/cov-2/560-ignoring-testing-performance/file"
                fileSize="47100"
                type="application/pdf"
                medium="document"
           />
           <media:title type="plain">Ignoring testing performance</media:title>
           <media:description type="html"><![CDATA[<p>Christoph Buchta et al., The Lancet Microbe</p>
<p>DOI: 10.1016/S2666-5247(23)00030-7</p>]]></media:description>
                      <guid isPermaLink="true">https://oequasta.at/de/publikationen/cov-2/560-ignoring-testing-performance?format=html</guid>
           <description><![CDATA[<p>Christoph Buchta et al., The Lancet Microbe</p>
<p>DOI: 10.1016/S2666-5247(23)00030-7</p>]]></description>
           <author>office@webkonzepte.at (Super User)</author>
           <category>SARS CoV-2</category>
           <pubDate>Mon, 13 Feb 2023 09:58:50 +0100</pubDate>
       </item>
              <item>
           <title>Disharmonic antibody quantification</title>
           <link>https://oequasta.at/de/publikationen/cov-2/559-disharmonic-antibody-quantification?format=html</link>
           <enclosure url="https://oequasta.at/de/publikationen/cov-2/559-disharmonic-antibody-quantification/file" length="1302473" type="application/pdf" />
           <media:content
                url="https://oequasta.at/de/publikationen/cov-2/559-disharmonic-antibody-quantification/file"
                fileSize="1302473"
                type="application/pdf"
                medium="document"
           />
           <media:title type="plain">Disharmonic antibody quantification</media:title>
           <media:description type="html"><![CDATA[<p>Christoph Buchta and David Springer, et al., Clin Chem Lab Med 2023</p>
<p>DOI: 10.1515/cclm-2022-1161</p>]]></media:description>
                      <guid isPermaLink="true">https://oequasta.at/de/publikationen/cov-2/559-disharmonic-antibody-quantification?format=html</guid>
           <description><![CDATA[<p>Christoph Buchta and David Springer, et al., Clin Chem Lab Med 2023</p>
<p>DOI: 10.1515/cclm-2022-1161</p>]]></description>
           <author>office@webkonzepte.at (Super User)</author>
           <category>SARS CoV-2</category>
           <pubDate>Mon, 13 Feb 2023 09:58:49 +0100</pubDate>
       </item>
              <item>
           <title>Analytische, diagnostische und rechtliche Aspekte der SARS-CoV-2 PCR</title>
           <link>https://oequasta.at/de/publikationen/cov-2/549-analytische-diagnostische-und-rechtliche-aspekte-der-sars-cov-2-pcr?format=html</link>
           <enclosure url="https://oequasta.at/de/publikationen/cov-2/549-analytische-diagnostische-und-rechtliche-aspekte-der-sars-cov-2-pcr/file" length="" type="application/pdf" />
           <media:content
                url="https://oequasta.at/de/publikationen/cov-2/549-analytische-diagnostische-und-rechtliche-aspekte-der-sars-cov-2-pcr/file"
                fileSize=""
                type="application/pdf"
                medium="document"
           />
           <media:title type="plain">Analytische, diagnostische und rechtliche Aspekte der SARS-CoV-2 PCR</media:title>
           <media:description type="html"><![CDATA[<p>Griesmacher et al., Österreichische Zeitschrift für das Ärztliche Gutachten</p>]]></media:description>
                      <guid isPermaLink="true">https://oequasta.at/de/publikationen/cov-2/549-analytische-diagnostische-und-rechtliche-aspekte-der-sars-cov-2-pcr?format=html</guid>
           <description><![CDATA[<p>Griesmacher et al., Österreichische Zeitschrift für das Ärztliche Gutachten</p>]]></description>
           <author>office@webkonzepte.at (Super User)</author>
           <category>SARS CoV-2</category>
           <pubDate>Tue, 10 Jan 2023 19:14:55 +0100</pubDate>
       </item>
              <item>
           <title>Converting to an international unit system improves harmonization of results for SARS-CoV-2 quantification: Results from multiple external quality assessments</title>
           <link>https://oequasta.at/de/publikationen/cov-2/547-converting-to-an-international-unit-system-improves-harmonization-of-results-for-sars-cov-2-quantification-results-from-multiple-external-quality-assessments?format=html</link>
           <enclosure url="https://oequasta.at/de/publikationen/cov-2/547-converting-to-an-international-unit-system-improves-harmonization-of-results-for-sars-cov-2-quantification-results-from-multiple-external-quality-assessments/file" length="" type="" />
           <media:content
                url="https://oequasta.at/de/publikationen/cov-2/547-converting-to-an-international-unit-system-improves-harmonization-of-results-for-sars-cov-2-quantification-results-from-multiple-external-quality-assessments/file"
                fileSize=""
                type=""
                medium="document"
           />
           <media:title type="plain">Converting to an international unit system improves harmonization of results for SARS-CoV-2 quantification: Results from multiple external quality assessments</media:title>
           <media:description type="html"><![CDATA[<p>Buchta et al., J Clin Virol. 2023 Jan;158:105352</p>
<p>DOI: 10.1016/j.jcv.2022.105352</p>]]></media:description>
                      <guid isPermaLink="true">https://oequasta.at/de/publikationen/cov-2/547-converting-to-an-international-unit-system-improves-harmonization-of-results-for-sars-cov-2-quantification-results-from-multiple-external-quality-assessments?format=html</guid>
           <description><![CDATA[<p>Buchta et al., J Clin Virol. 2023 Jan;158:105352</p>
<p>DOI: 10.1016/j.jcv.2022.105352</p>]]></description>
           <author>office@webkonzepte.at (Super User)</author>
           <category>SARS CoV-2</category>
           <pubDate>Tue, 10 Jan 2023 19:12:17 +0100</pubDate>
       </item>
              <item>
           <title>Results of a SARS-CoV-2 virus genome detection external quality assessment round focusing on sensitivity of assays and pooling of samples</title>
           <link>https://oequasta.at/de/publikationen/cov-2/548-results-of-a-sars-cov-2-virus-genome-detection-external-quality-assessment-round-focusing-on-sensitivity-of-assays-and-pooling-of-samples?format=html</link>
           <enclosure url="https://oequasta.at/de/publikationen/cov-2/548-results-of-a-sars-cov-2-virus-genome-detection-external-quality-assessment-round-focusing-on-sensitivity-of-assays-and-pooling-of-samples/file" length="" type="" />
           <media:content
                url="https://oequasta.at/de/publikationen/cov-2/548-results-of-a-sars-cov-2-virus-genome-detection-external-quality-assessment-round-focusing-on-sensitivity-of-assays-and-pooling-of-samples/file"
                fileSize=""
                type=""
                medium="document"
           />
           <media:title type="plain">Results of a SARS-CoV-2 virus genome detection external quality assessment round focusing on sensitivity of assays and pooling of samples</media:title>
           <media:description type="html"><![CDATA[<p>Buchta et al., Clin Chem Lab Med. 2022 May 23;60(8):1308-1312</p>
<p>DOI: 10.1515/cclm-2022-0263</p>]]></media:description>
                      <guid isPermaLink="true">https://oequasta.at/de/publikationen/cov-2/548-results-of-a-sars-cov-2-virus-genome-detection-external-quality-assessment-round-focusing-on-sensitivity-of-assays-and-pooling-of-samples?format=html</guid>
           <description><![CDATA[<p>Buchta et al., Clin Chem Lab Med. 2022 May 23;60(8):1308-1312</p>
<p>DOI: 10.1515/cclm-2022-0263</p>]]></description>
           <author>office@webkonzepte.at (Super User)</author>
           <category>SARS CoV-2</category>
           <pubDate>Mon, 23 May 2022 20:14:13 +0200</pubDate>
       </item>
              <item>
           <title>The importance of external quality assessment data in evaluating SARS-CoV-2 virus genome detection assays</title>
           <link>https://oequasta.at/de/publikationen/cov-2/550-the-importance-of-external-quality-assessment-data-in-evaluating-sars-cov-2-virus-genome-detection-assays?format=html</link>
           <enclosure url="https://oequasta.at/de/publikationen/cov-2/550-the-importance-of-external-quality-assessment-data-in-evaluating-sars-cov-2-virus-genome-detection-assays/file" length="" type="" />
           <media:content
                url="https://oequasta.at/de/publikationen/cov-2/550-the-importance-of-external-quality-assessment-data-in-evaluating-sars-cov-2-virus-genome-detection-assays/file"
                fileSize=""
                type=""
                medium="document"
           />
           <media:title type="plain">The importance of external quality assessment data in evaluating SARS-CoV-2 virus genome detection assays</media:title>
           <media:description type="html"><![CDATA[<p>Buchta et al., Lancet Microbe. 2022 Mar;3(3):e168</p>
<p>DOI: 10.1016/S2666-5247(22)00003-9</p>]]></media:description>
                      <guid isPermaLink="true">https://oequasta.at/de/publikationen/cov-2/550-the-importance-of-external-quality-assessment-data-in-evaluating-sars-cov-2-virus-genome-detection-assays?format=html</guid>
           <description><![CDATA[<p>Buchta et al., Lancet Microbe. 2022 Mar;3(3):e168</p>
<p>DOI: 10.1016/S2666-5247(22)00003-9</p>]]></description>
           <author>office@webkonzepte.at (Super User)</author>
           <category>SARS CoV-2</category>
           <pubDate>Tue, 01 Mar 2022 19:16:37 +0100</pubDate>
       </item>
              <item>
           <title>Strategie zur Virusvariantensurveillance</title>
           <link>https://oequasta.at/de/publikationen/cov-2/535-strategie-zur-virusvariantensurveillance?format=html</link>
           <enclosure url="https://oequasta.at/de/publikationen/cov-2/535-strategie-zur-virusvariantensurveillance/file" length="147446" type="application/pdf" />
           <media:content
                url="https://oequasta.at/de/publikationen/cov-2/535-strategie-zur-virusvariantensurveillance/file"
                fileSize="147446"
                type="application/pdf"
                medium="document"
           />
           <media:title type="plain">Strategie zur Virusvariantensurveillance</media:title>
           <media:description type="html"><![CDATA[]]></media:description>
                      <guid isPermaLink="true">https://oequasta.at/de/publikationen/cov-2/535-strategie-zur-virusvariantensurveillance?format=html</guid>
           <description><![CDATA[]]></description>
           <author>jutta.pilecky@oequasta.at (Jutta Pilecky)</author>
           <category>SARS CoV-2</category>
           <pubDate>Tue, 15 Feb 2022 14:44:17 +0100</pubDate>
       </item>
              <item>
           <title>Inadequate design of mutation detection panels prevents interpretation of variants of concern: results of an external quality assessment for SARS-CoV-2 variant detection.</title>
           <link>https://oequasta.at/de/publikationen/cov-2/551-inadequate-design-of-mutation-detection-panels-prevents-interpretation-of-variants-of-concern-results-of-an-external-quality-assessment-for-sars-cov-2-variant-detection-1?format=html</link>
           <enclosure url="https://oequasta.at/de/publikationen/cov-2/551-inadequate-design-of-mutation-detection-panels-prevents-interpretation-of-variants-of-concern-results-of-an-external-quality-assessment-for-sars-cov-2-variant-detection-1/file" length="" type="" />
           <media:content
                url="https://oequasta.at/de/publikationen/cov-2/551-inadequate-design-of-mutation-detection-panels-prevents-interpretation-of-variants-of-concern-results-of-an-external-quality-assessment-for-sars-cov-2-variant-detection-1/file"
                fileSize=""
                type=""
                medium="document"
           />
           <media:title type="plain">Inadequate design of mutation detection panels prevents interpretation of variants of concern: results of an external quality assessment for SARS-CoV-2 variant detection.</media:title>
           <media:description type="html"><![CDATA[<p>Buchta et al., Clin Chem Lab Med. 2021 Nov 8;60(2):291-298</p>
<p>DOI: 10.1515/cclm-2021-0889</p>]]></media:description>
                      <guid isPermaLink="true">https://oequasta.at/de/publikationen/cov-2/551-inadequate-design-of-mutation-detection-panels-prevents-interpretation-of-variants-of-concern-results-of-an-external-quality-assessment-for-sars-cov-2-variant-detection-1?format=html</guid>
           <description><![CDATA[<p>Buchta et al., Clin Chem Lab Med. 2021 Nov 8;60(2):291-298</p>
<p>DOI: 10.1515/cclm-2021-0889</p>]]></description>
           <author>office@webkonzepte.at (Super User)</author>
           <category>SARS CoV-2</category>
           <pubDate>Sat, 01 Jan 2022 00:00:00 +0100</pubDate>
       </item>
              <item>
           <title>Informationen zur Einmeldung von SARS-CoV-2-Testungen (vom 15. Oktober 2021)</title>
           <link>https://oequasta.at/de/publikationen/cov-2/532-informationen-zur-einmeldung-von-sars-cov-2-testungen-vom-15-oktober-2021?format=html</link>
           <enclosure url="https://oequasta.at/de/publikationen/cov-2/532-informationen-zur-einmeldung-von-sars-cov-2-testungen-vom-15-oktober-2021/file" length="62797" type="application/pdf" />
           <media:content
                url="https://oequasta.at/de/publikationen/cov-2/532-informationen-zur-einmeldung-von-sars-cov-2-testungen-vom-15-oktober-2021/file"
                fileSize="62797"
                type="application/pdf"
                medium="document"
           />
           <media:title type="plain">Informationen zur Einmeldung von SARS-CoV-2-Testungen (vom 15. Oktober 2021)</media:title>
           <media:description type="html"><![CDATA[]]></media:description>
                      <guid isPermaLink="true">https://oequasta.at/de/publikationen/cov-2/532-informationen-zur-einmeldung-von-sars-cov-2-testungen-vom-15-oktober-2021?format=html</guid>
           <description><![CDATA[]]></description>
           <author>jutta.pilecky@oequasta.at (Jutta Pilecky)</author>
           <category>SARS CoV-2</category>
           <pubDate>Mon, 29 Nov 2021 16:21:13 +0100</pubDate>
       </item>
              <item>
           <title>Präsentation J.V. Camp – Rundversuch SARS-CoV-2 mutationsspezifische PCR</title>
           <link>https://oequasta.at/de/publikationen/cov-2/527-praesentation-j-v-camp-rundversuch-sars-cov-2-mutationsspezifische-pcr?format=html</link>
           <enclosure url="https://oequasta.at/de/publikationen/cov-2/527-praesentation-j-v-camp-rundversuch-sars-cov-2-mutationsspezifische-pcr/file" length="" type="" />
           <media:content
                url="https://oequasta.at/de/publikationen/cov-2/527-praesentation-j-v-camp-rundversuch-sars-cov-2-mutationsspezifische-pcr/file"
                fileSize=""
                type=""
                medium="document"
           />
           <media:title type="plain">Präsentation J.V. Camp – Rundversuch SARS-CoV-2 mutationsspezifische PCR</media:title>
           <media:description type="html"><![CDATA[]]></media:description>
                      <guid isPermaLink="true">https://oequasta.at/de/publikationen/cov-2/527-praesentation-j-v-camp-rundversuch-sars-cov-2-mutationsspezifische-pcr?format=html</guid>
           <description><![CDATA[]]></description>
           <author>jutta.pilecky@oequasta.at (Jutta Pilecky)</author>
           <category>SARS CoV-2</category>
           <pubDate>Tue, 02 Nov 2021 15:27:14 +0100</pubDate>
       </item>
              <item>
           <title>A look at the precision, sensitivity and specificity of SARS-CoV-2 RT-PCR assays through a dedicated external quality assessment round</title>
           <link>https://oequasta.at/de/publikationen/cov-2/552-a-look-at-the-precision-sensitivity-and-specificity-of-sars-cov-2-rt-pcr-assays-through-a-dedicated-external-quality-assessment-round-2?format=html</link>
           <enclosure url="https://oequasta.at/de/publikationen/cov-2/552-a-look-at-the-precision-sensitivity-and-specificity-of-sars-cov-2-rt-pcr-assays-through-a-dedicated-external-quality-assessment-round-2/file" length="" type="" />
           <media:content
                url="https://oequasta.at/de/publikationen/cov-2/552-a-look-at-the-precision-sensitivity-and-specificity-of-sars-cov-2-rt-pcr-assays-through-a-dedicated-external-quality-assessment-round-2/file"
                fileSize=""
                type=""
                medium="document"
           />
           <media:title type="plain">A look at the precision, sensitivity and specificity of SARS-CoV-2 RT-PCR assays through a dedicated external quality assessment round</media:title>
           <media:description type="html"><![CDATA[<p>Buchta et al., Clin Chem Lab Med. 2021 Oct 20;60(2):e34-e37</p>]]></media:description>
                      <guid isPermaLink="true">https://oequasta.at/de/publikationen/cov-2/552-a-look-at-the-precision-sensitivity-and-specificity-of-sars-cov-2-rt-pcr-assays-through-a-dedicated-external-quality-assessment-round-2?format=html</guid>
           <description><![CDATA[<p>Buchta et al., Clin Chem Lab Med. 2021 Oct 20;60(2):e34-e37</p>]]></description>
           <author>office@webkonzepte.at (Super User)</author>
           <category>SARS CoV-2</category>
           <pubDate>Wed, 20 Oct 2021 01:00:00 +0200</pubDate>
       </item>
              <item>
           <title>RT-PCR based SARS-CoV-2 variant screening assays require careful quality control</title>
           <link>https://oequasta.at/de/publikationen/cov-2/522-rt-pcr-based-sars-cov-2-variant-screening-assays-require-careful-quality-control?format=html</link>
           <enclosure url="https://oequasta.at/de/publikationen/cov-2/522-rt-pcr-based-sars-cov-2-variant-screening-assays-require-careful-quality-control/file" length="" type="" />
           <media:content
                url="https://oequasta.at/de/publikationen/cov-2/522-rt-pcr-based-sars-cov-2-variant-screening-assays-require-careful-quality-control/file"
                fileSize=""
                type=""
                medium="document"
           />
           <media:title type="plain">RT-PCR based SARS-CoV-2 variant screening assays require careful quality control</media:title>
           <media:description type="html"><![CDATA[<p>Camp et al., J Clin Virol. 2021 Aug;141:104905</p>
<p>DOI: 10.1016/j.jcv.2021.104905</p>]]></media:description>
                      <guid isPermaLink="true">https://oequasta.at/de/publikationen/cov-2/522-rt-pcr-based-sars-cov-2-variant-screening-assays-require-careful-quality-control?format=html</guid>
           <description><![CDATA[<p>Camp et al., J Clin Virol. 2021 Aug;141:104905</p>
<p>DOI: 10.1016/j.jcv.2021.104905</p>]]></description>
           <author>office@webkonzepte.at (Super User)</author>
           <category>SARS CoV-2</category>
           <pubDate>Thu, 22 Jul 2021 07:38:34 +0200</pubDate>
       </item>
              <item>
           <title>The versatility of external quality assessment for the surveillance of laboratory and in vitro diagnostic performance: SARS-CoV-2 viral genome detection in Austria</title>
           <link>https://oequasta.at/de/publikationen/cov-2/554-the-versatility-of-external-quality-assessment-for-the-surveillance-of-laboratory-and-in-vitro-diagnostic-performance-sars-cov-2-viral-genome-detection-in-austria?format=html</link>
           <enclosure url="https://oequasta.at/de/publikationen/cov-2/554-the-versatility-of-external-quality-assessment-for-the-surveillance-of-laboratory-and-in-vitro-diagnostic-performance-sars-cov-2-viral-genome-detection-in-austria/file" length="" type="" />
           <media:content
                url="https://oequasta.at/de/publikationen/cov-2/554-the-versatility-of-external-quality-assessment-for-the-surveillance-of-laboratory-and-in-vitro-diagnostic-performance-sars-cov-2-viral-genome-detection-in-austria/file"
                fileSize=""
                type=""
                medium="document"
           />
           <media:title type="plain">The versatility of external quality assessment for the surveillance of laboratory and in vitro diagnostic performance: SARS-CoV-2 viral genome detection in Austria</media:title>
           <media:description type="html"><![CDATA[<p>Buchta et al., Clin Chem Lab Med. 2021 Jun 30;59(10):1735-1744</p>]]></media:description>
                      <guid isPermaLink="true">https://oequasta.at/de/publikationen/cov-2/554-the-versatility-of-external-quality-assessment-for-the-surveillance-of-laboratory-and-in-vitro-diagnostic-performance-sars-cov-2-viral-genome-detection-in-austria?format=html</guid>
           <description><![CDATA[<p>Buchta et al., Clin Chem Lab Med. 2021 Jun 30;59(10):1735-1744</p>]]></description>
           <author>office@webkonzepte.at (Super User)</author>
           <category>SARS CoV-2</category>
           <pubDate>Wed, 30 Jun 2021 01:00:00 +0200</pubDate>
       </item>
              <item>
           <title>Die Bedeutung von neutralisierenden Antikörpern in der SARSCoV- 2-Diagnostik</title>
           <link>https://oequasta.at/de/publikationen/cov-2/513-die-bedeutung-von-neutralisierenden-antikoerpern-in-der-sarscov-2-diagnostik-1?format=html</link>
           <enclosure url="https://oequasta.at/de/publikationen/cov-2/513-die-bedeutung-von-neutralisierenden-antikoerpern-in-der-sarscov-2-diagnostik-1/file" length="230344" type="application/pdf" />
           <media:content
                url="https://oequasta.at/de/publikationen/cov-2/513-die-bedeutung-von-neutralisierenden-antikoerpern-in-der-sarscov-2-diagnostik-1/file"
                fileSize="230344"
                type="application/pdf"
                medium="document"
           />
           <media:title type="plain">Die Bedeutung von neutralisierenden Antikörpern in der SARSCoV- 2-Diagnostik</media:title>
           <media:description type="html"><![CDATA[]]></media:description>
                      <guid isPermaLink="true">https://oequasta.at/de/publikationen/cov-2/513-die-bedeutung-von-neutralisierenden-antikoerpern-in-der-sarscov-2-diagnostik-1?format=html</guid>
           <description><![CDATA[]]></description>
           <author>jutta.pilecky@oequasta.at (Jutta Pilecky)</author>
           <category>SARS CoV-2</category>
           <pubDate>Wed, 28 Apr 2021 11:46:57 +0200</pubDate>
       </item>
              <item>
           <title>Variability of cycle threshold values in an external quality assessment scheme for detection of the SARS-CoV-2 virus genome by RT-PCR</title>
           <link>https://oequasta.at/de/publikationen/cov-2/555-variability-of-cycle-threshold-values-in-an-external-quality-assessment-scheme-for-detection-of-the-sars-cov-2-virus-genome-by-rt-pcr-1?format=html</link>
           <enclosure url="https://oequasta.at/de/publikationen/cov-2/555-variability-of-cycle-threshold-values-in-an-external-quality-assessment-scheme-for-detection-of-the-sars-cov-2-virus-genome-by-rt-pcr-1/file" length="" type="" />
           <media:content
                url="https://oequasta.at/de/publikationen/cov-2/555-variability-of-cycle-threshold-values-in-an-external-quality-assessment-scheme-for-detection-of-the-sars-cov-2-virus-genome-by-rt-pcr-1/file"
                fileSize=""
                type=""
                medium="document"
           />
           <media:title type="plain">Variability of cycle threshold values in an external quality assessment scheme for detection of the SARS-CoV-2 virus genome by RT-PCR</media:title>
           <media:description type="html"><![CDATA[<p>Buchta et al., Clin Chem Lab Med. 2020 Dec 16;59(5):987-994</p>]]></media:description>
                      <guid isPermaLink="true">https://oequasta.at/de/publikationen/cov-2/555-variability-of-cycle-threshold-values-in-an-external-quality-assessment-scheme-for-detection-of-the-sars-cov-2-virus-genome-by-rt-pcr-1?format=html</guid>
           <description><![CDATA[<p>Buchta et al., Clin Chem Lab Med. 2020 Dec 16;59(5):987-994</p>]]></description>
           <author>office@webkonzepte.at (Super User)</author>
           <category>SARS CoV-2</category>
           <pubDate>Wed, 16 Dec 2020 00:00:00 +0100</pubDate>
       </item>
              <item>
           <title>IFCC Guidelines serolog  SARS-2 Testung</title>
           <link>https://oequasta.at/de/publikationen/cov-2/501-ifcc-guidelines-serolog-sars-2-testung-1?format=html</link>
           <enclosure url="https://oequasta.at/de/publikationen/cov-2/501-ifcc-guidelines-serolog-sars-2-testung-1/file" length="252346" type="application/pdf" />
           <media:content
                url="https://oequasta.at/de/publikationen/cov-2/501-ifcc-guidelines-serolog-sars-2-testung-1/file"
                fileSize="252346"
                type="application/pdf"
                medium="document"
           />
           <media:title type="plain">IFCC Guidelines serolog  SARS-2 Testung</media:title>
           <media:description type="html"><![CDATA[]]></media:description>
                      <guid isPermaLink="true">https://oequasta.at/de/publikationen/cov-2/501-ifcc-guidelines-serolog-sars-2-testung-1?format=html</guid>
           <description><![CDATA[]]></description>
           <author>jutta.pilecky@oequasta.at (Jutta Pilecky)</author>
           <category>SARS CoV-2</category>
           <pubDate>Mon, 07 Dec 2020 16:58:54 +0100</pubDate>
       </item>
              <item>
           <title>IFCC Guidelines molekulare SARS-2 Testung</title>
           <link>https://oequasta.at/de/publikationen/cov-2/500-ifcc-guidelines-molekulare-sars-2-testung-1?format=html</link>
           <enclosure url="https://oequasta.at/de/publikationen/cov-2/500-ifcc-guidelines-molekulare-sars-2-testung-1/file" length="250684" type="application/pdf" />
           <media:content
                url="https://oequasta.at/de/publikationen/cov-2/500-ifcc-guidelines-molekulare-sars-2-testung-1/file"
                fileSize="250684"
                type="application/pdf"
                medium="document"
           />
           <media:title type="plain">IFCC Guidelines molekulare SARS-2 Testung</media:title>
           <media:description type="html"><![CDATA[]]></media:description>
                      <guid isPermaLink="true">https://oequasta.at/de/publikationen/cov-2/500-ifcc-guidelines-molekulare-sars-2-testung-1?format=html</guid>
           <description><![CDATA[]]></description>
           <author>jutta.pilecky@oequasta.at (Jutta Pilecky)</author>
           <category>SARS CoV-2</category>
           <pubDate>Mon, 07 Dec 2020 16:58:29 +0100</pubDate>
       </item>
          </channel>
</rss>